Glomerular disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:93548
Who is this for?
Show terms as
7Active trials56Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jul 2026Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

PT. Prodia Stem Cell Indonesia — PHASE1, PHASE2

TrialRECRUITING
Mar 2026Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Jiangsu Hansoh Pharmaceutical Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Feb 2026A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

AstraZeneca — PHASE2

TrialRECRUITING
Feb 2026Efficacy and Safety of the Ultrasound Stimulation Device NEFRONIX in Patients With Chronic Kidney Disease

Anasonic — NA

TrialNOT YET RECRUITING
Feb 2026MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure

MediBeacon — NA

TrialNOT YET RECRUITING
Jul 2025Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Novartis Pharmaceuticals — PHASE3

TrialRECRUITING
Jul 2025Evaluation of the Performance of Glomerular Filtration Rate Measurement Using CT Urography in Patients With a GFR Below 60 mL/Min/1.73 m²

Assistance Publique - Hôpitaux de Paris — NA

TrialNOT YET RECRUITING
Jul 2025The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy

Luo Yaping — NA

TrialNOT YET RECRUITING
Jul 2025Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Enyo Pharma — PHASE2

TrialRECRUITING
Jun 2025MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Shanghai Changzheng Hospital — PHASE1, PHASE2

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Glomerular disease.

7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

7 recruitingView all trials with filters →
Phase 31 trial
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Phase 3
Actively Recruiting
PI: Novartis Pharmaceuticals (Novartis Pharmaceuticals) · Sites: Denver, Colorado; Clifton Park, New York +4 more · Age: 18–100 yrs
View on ClinicalTrials.gov ↗I'm interested →
Phase 41 trial
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
Phase 4
Actively Recruiting
PI: Xiangmei Chen, PhD (Chinese PLA General Hospital, Beijing, China) · Sites: Beijing, Beijing Municipality · Age: 18–75 yrs
View on ClinicalTrials.gov ↗I'm interested →
Phase 21 trial
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Phase 2
Actively Recruiting
PI: Meryl A Waldman, M.D. (National Institute of Diabetes and Digestive and K) · Sites: Bethesda, Maryland; Bethesda, Maryland · Age: 18–90 yrs
View on ClinicalTrials.gov ↗I'm interested →
Other4 trials
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Actively Recruiting
PI: Eloise Salmon, M.D. (University of Michigan) · Sites: Ann Arbor, Michigan · Age: 2–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
Actively Recruiting
PI: Xue Qing Yu, M.D. & Ph.D. (First Affiliated Hospital, Sun Yat-Sen University) · Sites: Guangzhou, Guangdong · Age: 14–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Actively Recruiting
PI: Dong Ki Kim, MD, PhD (Seoul National University Hospital) · Sites: Chuncheon; Daegu +4 more
View on ClinicalTrials.gov ↗I'm interested →
The Impact of Glomerular Disorders on Bone Quality and Strength
Actively Recruiting
PI: Thomas L. Nickolas, MD (Columbia University) · Sites: New York, New York; Philadelphia, Pennsylvania · Age: 5–55 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

Showing 25 of 56View all specialists →
MM
Meryl A Waldman, M.D.
BETHESDA, MD
Specialist
PI on 2 active trials
DS
Domenico Santoro
Specialist
2 Glomerular disease publications
LL
Liz Lightstone
Specialist
2 Glomerular disease publications
SA
Sharon G Adler
Specialist
2 Glomerular disease publications
JC
Joanna Cunanan
SICKLERVILLE, NJ
Specialist
1 Glomerular disease publication
EL
Elisa Longhitano
Specialist
2 Glomerular disease publications
SA
Syeda Behjat Ahmad
Specialist
1 Glomerular disease publication
VM
Veronica Maressa
Specialist
2 Glomerular disease publications
WS
William E Smoyer
COLUMBUS, OH
Specialist
2 Glomerular disease publications
CC
Chiara Casuscelli
Specialist
2 Glomerular disease publications
SC
Silvia Di Carlo
Specialist
2 Glomerular disease publications
JT
Jonathan P Troost
Specialist
2 Glomerular disease publications
LP
Luigi Peritore
Specialist
2 Glomerular disease publications
DZ
Daniel Zhang
Specialist
1 Glomerular disease publication
SS
Sanjeev Sethi
ROCHESTER, MN
Specialist
2 Glomerular disease publications
TP
Tevfik Ecder, Professor
Specialist
PI on 1 active trial
YM
Yasar Caliskan, MD
NASHVILLE, TN
Specialist
PI on 3 active trials
MM
Michael Mayr, MD
Bagamoyo, Coast Region
Specialist

Rare Disease Specialist

PI on 2 active trials
JM
Jeffrey B Kopp, M.D.
GUILFORD, CT
Specialist
PI on 5 active trials
RP
Rian Dişçi, Professor
Specialist
PI on 1 active trial2 Glomerular disease publications
HM
Huji Xu, Ph.D, MD
Specialist
PI on 2 active trials
AM
Anirban Ganguli, M.D.
WASHINGTON, DC
Specialist
PI on 2 active trials
NP
Neşe Çolak, Professor
Specialist
PI on 1 active trial
FF
Fatih Tufan, Fellow
Specialist
PI on 1 active trial
RG
Rousseau Gama
Specialist
PI on 2 active trials7 Glomerular disease publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Glomerular disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Glomerular diseaseForum →

No community posts yet. Be the first to share your experience with Glomerular disease.

Start the conversation →

Latest news about Glomerular disease

Disease timeline:

New recruiting trial: The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: IgA Nephropathy Biomarkers Evaluation Study (INTEREST)

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Study of Ravulizumab in Pediatric Participants With Primary IgAN

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

A new clinical trial is recruiting patients for Glomerular disease

New recruiting trial: Study of BHV-1400 in IgA Nephropathy

A new clinical trial is recruiting patients for Glomerular disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Glomerular disease

Are there clinical trials for Glomerular disease?

Yes — 7 recruiting clinical trials are currently listed for Glomerular disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Glomerular disease?

25 specialists and care centers treating Glomerular disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.